Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 670.1 M789 M702.3 M686.1 M51.5 M 2.23 B Research & development ————— — Operating income 28.2 M-25.3 M66.6 M80.6 M28.3 M 150.2 M Non-Operating Income, Total 5 M2.6 M5.8 M4 M7.3 M 19.7 M Interest expense, net of interest capitalized 22.5 M26 M24 M-167.9 M25.7 M -92.2 M Non-Operating Income, excl. Interest Expenses -17.5 M-23.4 M-18.2 M171.9 M-18.4 M 111.9 M Unusual income/expense ————— — Pretax income 16.7 M-41.8 M52.9 M65.6 M15.4 M 92.1 M Equity in earnings ————— — Taxes 11.1 M25.3 M34.9 M35.4 M12.9 M 108.5 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 5.6 M-67.1 M18 M30.2 M2.5 M -16.4 M Discontinued operations ————— — Net income 5.6 M-67.1 M18 M30.2 M2.5 M -16.4 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 5.6 M-67.1 M18 M30.2 M2.5 M -16.4 M Basic earnings per share (Basic EPS) 0.12-1.440.390.640.05 -0.36 Diluted earnings per share (Diluted EPS) 0.12-1.440.380.650.05 -0.36 Average basic shares outstanding 46.8 M46.5 M46.5 M46.6 M46.7 M — Diluted shares outstanding 47.3 M46.5 M46.9 M46.6 M47.1 M — EBITDA 201.4 M-114.9 M57 M67 M663.8 M 672.9 M EBIT 91.5 M-137.1 M34.9 M46.5 M643.6 M 587.9 M Cost of revenue 3.39 B3.76 B3.87 B3.95 B3.79 B 15.36 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 21.2 M22.2 M22.1 M20.5 M20.2 M 85 M